OTC · CIK 0001001233
SGMOQ SANGAMO THERAPEUTICS, INC
Insider trading from SEC Form 4. Last filing Nov 26, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
14
with a Form 4 at this company
Signals
Open-market buys and sells at SANGAMO THERAPEUTICS, INC, scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 73 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | FTax withholding Common Stock | -2,544 | $0.42 | $1,060 | 719,804 | Nov 26, 2025 |
| Nov 24, 2025 | Prathyusha Duraibabu PRINCIPAL FINANCIAL OFFICER | FTax withholding Common Stock | -2,544 | $0.42 | $1,060 | 696,718 | Nov 26, 2025 |
| Nov 24, 2025 | Nikunj Jain Principal Accounting Officer | FTax withholding Common Stock | -578 | $0.42 | $241 | 245,717 | Nov 26, 2025 |
| Nov 24, 2025 | Sandy Macrae PRESIDENT, CEO AND DIRECTOR | FTax withholding Common Stock | -7,488 | $0.42 | $3,120 | 2,049,534 | Nov 26, 2025 |
| Nov 24, 2025 | Scott B. Willoughby SVP, CHIEF LEGAL OFFICER, SECY | FTax withholding Common Stock | -2,035 | $0.42 | $848 | 702,086 | Nov 26, 2025 |
| Nov 24, 2025 | Gregory D Davis Head of Research & Technology | FTax withholding Common Stock | -723 | $0.42 | $301 | 193,791 | Nov 26, 2025 |
| Oct 22, 2025 | Gregory D Davis Head of Research & Technology | FTax withholding Common Stock | -6,708 | $0.66 | $4,427 | 194,514 | Oct 24, 2025 |
| Oct 22, 2025 | Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | FTax withholding Common Stock | -43,741 | $0.66 | $29k | 722,348 | Oct 24, 2025 |
| Oct 22, 2025 | Prathyusha Duraibabu PRINCIPAL FINANCIAL OFFICER | FTax withholding Common Stock | -45,225 | $0.66 | $30k | 699,262 | Oct 24, 2025 |
| Oct 22, 2025 | Nikunj Jain Principal Accounting Officer | FTax withholding Common Stock | -6,708 | $0.66 | $4,427 | 246,295 | Oct 24, 2025 |
| Oct 22, 2025 | Sandy Macrae PRESIDENT, CEO AND DIRECTOR | FTax withholding Common Stock | -126,950 | $0.66 | $84k | 2,057,022 | Oct 24, 2025 |
| Oct 22, 2025 | Scott B. Willoughby SVP, CHIEF LEGAL OFFICER, SECY | FTax withholding Common Stock | -44,122 | $0.66 | $29k | 704,121 | Oct 24, 2025 |
| Aug 24, 2025 | Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | FTax withholding Common Stock | -1,792 | $0.59 | $1,051 | 766,089 | Aug 26, 2025 |
| Aug 24, 2025 | Scott B. Willoughby SVP, CHIEF LEGAL OFFICER, SECY | FTax withholding Common Stock | -1,434 | $0.59 | $841 | 748,243 | Aug 26, 2025 |
| Aug 24, 2025 | Sandy Macrae PRESIDENT, CEO AND DIRECTOR | FTax withholding Common Stock | -7,488 | $0.59 | $4,390 | 2,183,972 | Aug 26, 2025 |
| Aug 24, 2025 | Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -1,792 | $0.59 | $1,051 | 744,487 | Aug 26, 2025 |
| Aug 24, 2025 | Gregory D Davis Head of Research & Technology | FTax withholding Common Stock | -723 | $0.59 | $424 | 201,222 | Aug 26, 2025 |
| Jul 22, 2025 | Gregory D Davis Head of Research & Technology | FTax withholding Common Stock | -6,708 | $0.48 | $3,219 | 201,945 | Jul 24, 2025 |
| Jul 22, 2025 | Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | FTax withholding Common Stock | -31,866 | $0.48 | $15k | 767,881 | Jul 24, 2025 |
| Jul 22, 2025 | Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -31,866 | $0.48 | $15k | 746,279 | Jul 24, 2025 |
| Jul 22, 2025 | Sandy Macrae PRESIDENT, CEO AND DIRECTOR | FTax withholding Common Stock | -126,950 | $0.48 | $61k | 2,191,460 | Jul 24, 2025 |
| Jul 22, 2025 | Scott B. Willoughby SVP, CHIEF LEGAL OFFICER, SECY | FTax withholding Common Stock | -31,866 | $0.48 | $15k | 749,677 | Jul 24, 2025 |
| Jun 12, 2025 | Karen L. Smith director | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 102,100 | Jun 16, 2025 |
| Jun 12, 2025 | H Stewart Parker director | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 112,600 | Jun 16, 2025 |
| Jun 12, 2025 | James R Meyers director | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 99,600 | Jun 16, 2025 |
| Jun 12, 2025 | John Markels director | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 96,384 | Jun 16, 2025 |
| Jun 12, 2025 | Margaret A Horn director | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 82,650 | Jun 16, 2025 |
| Jun 12, 2025 | Kenneth J. Hillan director | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 99,600 | Jun 16, 2025 |
| Jun 12, 2025 | Robert Carey director | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 99,600 | Jun 16, 2025 |
| Jun 12, 2025 | Courtney Beers director | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 82,650 | Jun 16, 2025 |
| Jun 12, 2025 | Margaret A Horn director | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 16, 2025 |
| Jun 12, 2025 | Robert Carey director | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 16, 2025 |
| Jun 12, 2025 | John Markels director | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 16, 2025 |
| Jun 12, 2025 | James R Meyers director | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 16, 2025 |
| Jun 12, 2025 | Courtney Beers director | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 16, 2025 |
| Jun 12, 2025 | H Stewart Parker director | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 16, 2025 |
| Jun 12, 2025 | Karen L. Smith director | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 16, 2025 |
| Jun 12, 2025 | Kenneth J. Hillan director | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 16, 2025 |
| May 24, 2025 | Scott B. Willoughby SVP, CHIEF LEGAL OFFICER, SECY | FTax withholding Common Stock | -1,433 | $0.47 | $678 | 781,543 | May 28, 2025 |
| May 24, 2025 | Sandy Macrae PRESIDENT, CEO AND DIRECTOR | FTax withholding Common Stock | -7,488 | $0.47 | $3,544 | 2,318,410 | May 28, 2025 |
| May 24, 2025 | Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | FTax withholding Common Stock | -1,792 | $0.47 | $848 | 799,747 | May 28, 2025 |
| May 24, 2025 | Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -1,792 | $0.47 | $848 | 778,145 | May 28, 2025 |
| May 24, 2025 | Gregory D Davis Head of Research & Technology | FTax withholding Common Stock | -723 | $0.47 | $342 | 208,653 | May 28, 2025 |
| Apr 22, 2025 | Gregory D Davis Head of Research & Technology | FTax withholding Common Stock | -6,708 | $0.78 | $5,207 | 209,376 | Apr 24, 2025 |
| Apr 22, 2025 | Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | FTax withholding Common Stock | -31,866 | $0.78 | $25k | 801,539 | Apr 24, 2025 |
| Apr 22, 2025 | Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -31,866 | $0.78 | $25k | 779,937 | Apr 24, 2025 |
| Apr 22, 2025 | Sandy Macrae PRESIDENT, CEO AND DIRECTOR | FTax withholding Common Stock | -126,950 | $0.78 | $99k | 2,325,898 | Apr 24, 2025 |
| Apr 22, 2025 | Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY | FTax withholding Common Stock | -31,866 | $0.78 | $25k | 782,976 | Apr 24, 2025 |
| Feb 24, 2025 | Gregory D Davis Head of Research & Technology | FTax withholding Common Stock | -705 | $1.00 | $705 | 166,865 | Feb 26, 2025 |
| Feb 24, 2025 | Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | FTax withholding Common Stock | -1,792 | $1.00 | $1,792 | 714,918 | Feb 26, 2025 |
| Feb 24, 2025 | Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -1,792 | $1.00 | $1,792 | 693,178 | Feb 26, 2025 |
| Feb 25, 2025 | Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | FTax withholding Common Stock | -1,513 | $0.96 | $1,447 | 713,405 | Feb 26, 2025 |
| Feb 25, 2025 | Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -1,375 | $0.96 | $1,315 | 691,803 | Feb 26, 2025 |
| Feb 25, 2025 | Gregory D Davis Head of Research & Technology | FTax withholding Common Stock | -507 | $0.96 | $485 | 166,358 | Feb 26, 2025 |
| Feb 25, 2025 | Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | AGrant or award Common Stock | +120,000 | $0.00 | $0 | 833,405 | Feb 26, 2025 |
| Feb 25, 2025 | Gregory D Davis Head of Research & Technology | AGrant or award Common Stock | +49,726 | $0.00 | $0 | 216,084 | Feb 26, 2025 |
| Feb 25, 2025 | Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER | AGrant or award Common Stock | +120,000 | $0.00 | $0 | 811,803 | Feb 26, 2025 |
| Feb 25, 2025 | Gregory D Davis Head of Research & Technology | AGrant or award Stock Option (Right to Buy)derivative | +99,454 | $0.00 | $0 | 99,454 | Feb 26, 2025 |
| Feb 25, 2025 | Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER | AGrant or award Stock Option (Right to Buy)derivative | +560,000 | $0.00 | $0 | 560,000 | Feb 26, 2025 |
| Feb 25, 2025 | Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | AGrant or award Stock Option (Right to Buy)derivative | +560,000 | $0.00 | $0 | 560,000 | Feb 26, 2025 |
| Jan 22, 2025 | Gregory D Davis Head of Research & Technology | FTax withholding Common Stock | -30,456 | $1.15 | $35k | 167,570 | Jan 24, 2025 |
| Jan 22, 2025 | Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | FTax withholding Common Stock | -129,593 | $1.15 | $149k | 716,710 | Jan 24, 2025 |
| Jan 22, 2025 | Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -129,242 | $1.15 | $149k | 694,970 | Jan 24, 2025 |
| Nov 24, 2024 | Gregory D Davis Head of Research & Technology | FTax withholding Common Stock | -721 | $1.88 | $1,355 | 202,368 | Nov 26, 2024 |
| Nov 24, 2024 | Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | FTax withholding Common Stock | -1,787 | $1.88 | $3,360 | 842,811 | Nov 26, 2024 |
| Nov 24, 2024 | Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -1,787 | $1.88 | $3,360 | 825,583 | Nov 26, 2024 |
| Nov 24, 2024 | Sandy Macrae PRESIDENT, CEO AND DIRECTOR | FTax withholding Common Stock | -7,473 | $1.88 | $14k | 2,519,225 | Nov 26, 2024 |
| Nov 24, 2024 | Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY | FTax withholding Common Stock | -1,430 | $1.88 | $2,688 | 828,571 | Nov 26, 2024 |
| Nov 25, 2024 | Gregory D Davis Head of Research & Technology | FTax withholding Common Stock | -505 | $1.94 | $980 | 201,863 | Nov 26, 2024 |
| Nov 25, 2024 | Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | FTax withholding Common Stock | -1,508 | $1.94 | $2,926 | 841,303 | Nov 26, 2024 |
| Nov 25, 2024 | Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -1,371 | $1.94 | $2,660 | 824,212 | Nov 26, 2024 |
| Nov 25, 2024 | Sandy Macrae PRESIDENT, CEO AND DIRECTOR | FTax withholding Common Stock | -10,642 | $1.94 | $21k | 2,508,583 | Nov 26, 2024 |
| Nov 25, 2024 | Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY | FTax withholding Common Stock | -1,371 | $1.94 | $2,660 | 827,200 | Nov 26, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Courtney Beersdirector
- Robert Careydirector
- Gregory D DavisHead of Research & Technology
- Nathalie Dubois-StringfellowSVP-CHIEF DEVELOPMENT OFFICER
- Prathyusha DuraibabuPRINCIPAL FINANCIAL OFFICER
- Kenneth J. Hillandirector
- Margaret A Horncoo, officer, director
- Nikunj JainPrincipal Accounting Officer
- Sandy MacraePRESIDENT, CEO AND DIRECTOR
- John Markelsdirector
- James R Meyersdirector
- H Stewart Parkerdirector
- Karen L. Smithdirector
- Scott B. WilloughbySVP, CHIEF LEGAL OFFICER, SECY
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.